The repertoire of Fos and Jun proteins expressed during the G(1) phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation

Citation
Sj. Cook et al., The repertoire of Fos and Jun proteins expressed during the G(1) phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation, MOL CELL B, 19(1), 1999, pp. 330-341
Citations number
104
Categorie Soggetti
Molecular Biology & Genetics
Journal title
MOLECULAR AND CELLULAR BIOLOGY
ISSN journal
02707306 → ACNP
Volume
19
Issue
1
Year of publication
1999
Pages
330 - 341
Database
ISI
SICI code
0270-7306(199901)19:1<330:TROFAJ>2.0.ZU;2-H
Abstract
In Rat-1 fibroblasts nonmitogenic doses of lysophosphatidic acid (LPA) stim ulate a transient activation of mitogen-activated protein kinase (MAPK), wh ereas mitogenic doses elicit a sustained response. This sustained phase of MAPK activation regulates cell fate decisions such as proliferation or diff erentiation, presumably by inducing a program of gene expression which is n ot observed in response to transient MAPK activation. We have examined the expression of members of the AP-1 transcription factor complex in response to stimulation with different doses of LPA. c-Fos, c-Jun, and JunB are indu ced rapidly in response to LPA stimulation, whereas Fra-1 and Fra-2 are ind uced after a significant lag. The expression of c-Fos is transient, whereas the expression of c-Jun, JunB, Fra-1, and Fra-2 is sustained. The early ex pression of c-Fos can be reconstituted with nonmitogenic doses of LPA, but the response is transient compared to that observed with mitogenic doses. I n contrast, expression of Fra-1, Fra-2, and JunB and optimal expression of c-Jun are observed only with doses of LPA which induce sustained MAPK activ ation and DNA synthesis. LPA-stimulated expression of c-Fos, Fra-1, Fra-2, c-Jun, and JunB is inhibited by the MEK1 inhibitor PD098059, indicating tha t the Raf-MEK-MAPK cascade is required for their expression. In cells expre ssing a conditionally active form of Raf-l (Delta Raf-1:ER), we observed th at selective, sustained activation of Raf-MEK-MAPK was sufficient to induce expression of Fra-1, Fra-2, and JunB but, interestingly, induced little or no c-Fos or c-Jun. The induction of c-Fos observed in response to LPA was strongly inhibited by buffering the intracellular [Ca2+]. Moreover, althoug h Raf activation or calcium ionophores induced little c-Fos expression, we observed a synergistic induction in response to the combination of Delta Ra f-1:FR and ionomycin. These results suggest that kinetically distinct phase s of MAPK activation serve to regulate the expression of distinct AP-1 comp onents such that sustained MAPK activation is required for the induced expr ession of Fra-1, Fra-2, c-Jun, and JunB. However, in contrast to the case f or Fra-1, Fra-2, and JunB, activation of the MAPK cascade alone is not suff icient to induce c-Fos expression, which rather requires cooperation with o ther signals such as Ca2+ mobilization. Finally, the identification of the Fra-1, Fra-2, c-Jun, and JunB genes as genes which are selectively regulate d by sustained MAPK activation or in response to activated Raf suggests tha t they are candidates to mediate certain of the effects of Ras proteins in oncogenic transformation.